Skip to main content
AMRX
NASDAQ Life Sciences

Amneal Closes Kashiv BioSciences Deal, Building Global Biosimilar Powerhouse

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.118
Mkt Cap
$5.793B
52W Low
$8.01
52W High
$19.26
52W Position info
126% above low
Off High info
5.9% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

AMRX has more than doubled off its 52-week low of $8.01.

Summary

Amneal completed its acquisition of Kashiv BioSciences, creating a fully integrated biosimilar platform with R&D, manufacturing, and commercial capabilities. The deal, approved by shareholders on July 31, adds a major long-term growth pillar targeting over $300 billion in projected biologic loss-of-exclusivity through the 2030s. Integration is underway, leveraging a decade-long relationship between the companies. This follows strong Q2 results and a recent term loan repricing, strengthening Amneal's financial position as it scales its biosimilar pipeline.

At the time of this announcement, AMRX was trading at $18.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.8B. The 52-week trading range was $8.01 to $19.26. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $19.46 info
Change: -$0.771 (-4%) info
Market Cap: $6.776B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.20
Real-time Price: $19.46 info
Change: -$0.745 (-4%) info
Market Cap: $6.776B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $19.46 info
Change: -$0.925 (-5%) info
Market Cap: $6.776B info
AMRX
Sep 18, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.71
Real-time Price: $19.46 info
Change: +$0.745 (+4%) info
Market Cap: $6.776B info
AMRX
Aug 12, 2026, 6:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $17.33
Real-time Price: $19.46 info
Change: +$2.13 (+12%) info
Market Cap: $6.776B info